Abstract

BackgroundAlthough numerous studies have shown that perineural invasion (PNI) is linked to prostate cancer (PCa) risk, the results have been inconsistent. This study aimed to explore the association between PNI and biochemical recurrence (BCR) in patients with PCa following radical prostatectomy (RP) or radiotherapy (RT).MethodsAccording to the PRISMA statement, we searched the PubMed, EMBASE, Chinese National Knowledge Infrastructure (CNKI) and Wan Fang databases from inception to May 2017. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) were extracted from eligible studies. Fixed or random effects model were used to calculate pooled HRs and 95% CIs according to heterogeneity. Publication bias was calculated by Begg’s test.ResultsUltimately, 19 cohort studies that met the eligibility criteria and that involved 13,412 patients (82-2,316 per study) were included in this meta-analysis. The results showed that PNI was associated with higher BCR rates in patients with PCa after RP (HR=1.23, 95% CI: 1.11, 1.36, p<0.001) or RT (HR=1.22, 95% CI: 1.12, 1.34, p<0.001). No potential publication bias was found among the included studies in the RP group (p-Begg = 0.124) or the RT group (p-Begg = 0.081).ConclusionsThis study suggests that the presence of PNI by histopathology is associated with higher risk of BCR in PCa following RP or RT, and could serve as an independent prognostic factor in patients with PCa.

Highlights

  • Numerous studies have shown that perineural invasion (PNI) is linked to prostate cancer (PCa) risk, the results have been inconsistent

  • 13 studies with 10,807patients were analyzed to investigate whether PNI acts as a predictive biomarker of biochemical recurrence (BCR) in PCa following radical prostatectomy (RP)

  • Six studies with 2,605 patients were evaluated to determine the relationship between PNI and the risk of BCR in PCa following RT

Read more

Summary

Introduction

Numerous studies have shown that perineural invasion (PNI) is linked to prostate cancer (PCa) risk, the results have been inconsistent. This study aimed to explore the association between PNI and biochemical recurrence (BCR) in patients with PCa following radical prostatectomy (RP) or radiotherapy (RT). Despite the use of radical prostatectomy (RP) and radiotherapy (RT) as initial therapies for localized PCa, approximately 18 % of patients eventually experience biochemical recurrence (BCR) [2]. Preoperative prostate-specific antigen (p-PSA) levels [3], Gleason score (GS) [4] and pathological stage [5] are widely used as traditional risk factors for BCR. There is a growing interest in the identification of a new prognostic marker to improve the evaluation of the likelihood of BCR in PCa patients after local treatment.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call